Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,500.00
+100.00 (7.14%)
At close: Mar 5, 2026
56.41%
Market Cap 15.61B
Revenue (ttm) 1.00B
Net Income (ttm) -13.37B
Shares Out 9.28M
EPS (ttm) -1,637.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,159
Average Volume 17,030
Open 1,500.00
Previous Close 1,400.00
Day's Range 1,400.00 - 1,600.00
52-Week Range 680.00 - 3,300.00
Beta -0.12
RSI 50.73
Earnings Date n/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops therapeutic drugs for non-alcoholic liver disease treatment and the anticancer field. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.